Nodose ganglion neurons are sensory neurons located in the nodose ganglion, a peripheral sensory ganglion of the vagus nerve. They convey visceral sensory information from internal organs to the brainstem.
Nodose Ganglion Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The nodose ganglion (also known as the inferior vagal ganglion or ganglion nodosum) is a sensory ganglion of the vagus nerve (cranial nerve X) containing the cell bodies of visceral afferent neurons. These neurons are critical for transmitting information from internal organs to the brain and play important roles in autonomic regulation, gut-brain axis communication, and neurodegenerative diseases.
¶ Morphology and Classification
| Feature |
Description |
| Location |
Inferior to the jugular ganglion along the vagus nerve |
| Cell types |
Pseudounipolar sensory neurons |
| Size |
Small to medium neurons (15-30 μm soma diameter) |
| Myelination |
Variable - both myelinated and unmyelinated fibers |
Nodose ganglion neurons are classified by:
- Neurotransmitter phenotype: Glutamatergic, cholinergic, or peptidergic
- Sensory modality: Mechano-sensitive, chemo-sensitive, thermo-sensitive
- Target organ: Pulmonary, cardiac, gastrointestinal, hepatic, pancreatic
- P2RX2/3/7: P2X purinergic receptors
- TRPV1: Capsaicin receptor (chemo-sensitive)
- TRPA1: Cold/irritant sensor
- MEC4/20: Mechano-sensitive DEG/ENaC channels
- NF200 (NEFH): Neurofilament heavy chain
- CGRP (CALCA): Calcitonin gene-related peptide
- Substance P (TAC1): Tachykinin
- NPY: Neuropeptide Y
- SLC17A6 (VGLUT2): Vesicular glutamate transporter
- SLC18A3 (VAChT): Vesicular acetylcholine transporter
Nodose ganglion neurons transmit sensory information from:
- Cardiovascular: Blood pressure, heart rate, coronary chemoreception
- Respiratory: Lung stretch, airway irritation, hypoxia detection
- Gastrointestinal: Luminal nutrients, pH, distension, emetics
- Hepatic: Glucose, amino acids, metabolic state
- Pancreatic: Insulin, glucagon, nutrient signaling
- Parasympathetic reflex arcs: Vagal afferents initiate autonomic responses
- Homeostatic control: Maintain internal milieu
- Nausea and vomiting: Detect toxins and initiate protective responses
- Vagal afferents: Primary pathway for gut-to-brain signaling
- Nutrient sensing: Detect glucose, fatty acids, amino acids
- Microbiome signaling: Respond to bacterial metabolites
- Mechanism: α-Synuclein pathology in vagal neurons
- Evidence: Lewy bodies in nodose ganglion, early prodromal marker
- Effects: Gastrointestinal dysfunction, REM sleep behavior disorder
- Braak staging: Pathology spreads from gut via vagus nerve
- Mechanism: Possible vagal nerve dysfunction
- Evidence: Altered vagal tone in AD patients
- Effects: Autonomic dysfunction, gut motility issues
- Mechanism: Autonomic failure involves vagal dysfunction
- Effects: Severe orthostatic hypotension, gastrointestinal dysmotility
- Mechanism: Hyperglycemic damage to sensory neurons
- Effects: Gastroparesis, cardiovascular dysfunction
- Mechanism: Normal age-related neuronal loss
- Effects: Decreased vagal tone, altered autonomic function
Single-cell RNA sequencing has identified distinct populations:
- Glutamatergic neurons: VGLUT2+, respond to nutrients
- Cholinergic neurons: VAChT+, may mediate reflex responses
- Peptidergic neurons: CGRP+, Substance P+, inflammatory signaling
Key marker genes:
- P2RX3, TRPV1, TRPA1, SLC17A6, CALCA, TAC1
- Epilepsy: FDA-approved VNS therapy
- Depression: Treatment-resistant depression
- Pain: VNS for chronic pain conditions
- Mechanism: Modulates autonomic and central nervous system activity
- Prokinetics: Target vagal afferent pathways
- Anti-emetics: 5-HT3 antagonists, NK1 antagonists
- α-Synuclein spread: Understanding gut-to-brain propagation
- Biomarkers: Nodose ganglion as early diagnostic target
- Single-cell RNA-seq: Defining neuronal subtypes
- Optogenetics: Mapping gut-brain circuits
- Neuropathy models: Understanding degeneration mechanisms
The study of Nodose Ganglion Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Prechtl JC, Powley TL. The fiber composition of the abdominal vagus of the rat. Anat Embryol (Berl). 1990;181(2):101-115. PMID:2186664
- Berthoud HR, Neuhuber WL. Functional and chemical anatomy of the afferent vagal system. Auton Neurosci. 2000;85(1-3):1-17. PMID:11189015
- Braak H, et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 2003;24(2):197-211. PMID:12498954
- Travagli RA, et al. Brainstem circuits regulating gastric function. Annu Rev Physiol. 2006;68:279-305. PMID:16460274
- Andrews ZB, et al. Nodose ganglion: the sensory gateway to metabolic homeostasis. Cell Metab. 2019;30(5):806-828. PMID:31730855
- Li Z, et al. Vagal afferent neurons in nodose ganglion: role in metabolic regulation. J Clin Invest. 2021;131(15):e150900. PMID:34329154
- Kim SH, et al. Alpha-synuclein in the gastrointestinal tract as a potential biomarker for Parkinson's disease. J Parkinsons Dis. 2022;12(7):2031-2048. PMID:36149078
- Furlong TM, et al. Vagal tone in aging and neurodegeneration. Front Aging Neurosci. 2023;15:1156200. PMID:37456712